Clinical Trials
32 trialsIntradermal, Fractional Dose of HPV Vaccines:
University of Washington
Immunogenicity of Fractional Dose of the HPV Vaccines
University of Washington
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Boston Medical Center
RIFT-HPV
Institut d'Investigació Biomèdica de Bellvitge
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
Mayo Clinic
Zopa Retreatment and Vector Shedding in Adults With RRP
Precigen, Inc
Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
Zhejiang Provincial Center for Disease Control and Prevention
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
The University of Texas Medical Branch, Galveston
Add-Vacc
London School of Hygiene and Tropical Medicine
ESCUDDO
National Cancer Institute (NCI)
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
Columbia University
AGO-Gard
Louisiana State University Health Sciences Center in New Orleans
TRAP-HPV
McGill University
9-VPH-MVIH
University Hospital Virgen de las Nieves
Immunogenicity of 9-valent HPV Vaccine
Instituto de Investigación Hospital Universitario La Paz
Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
Catalysis SL
HPV Vaccine Immunity in High-risk Women
Murdoch Childrens Research Institute
The KEN SHE Study on HPV-vaccine Efficacy
Massachusetts General Hospital
Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents
University of Washington
Treatment of HPV Infection in Perimenopausal and Postmenopausal Women
Qianfoshan Hospital
"Lactobacillus Crispatus M247, LSIL and Microbiota"
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
Xiamen Innovax Biotech Co., Ltd
PROM SSCOL
Centre Hospitalier Universitaire de la Réunion
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
Region Stockholm
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
Medstar Health Research Institute
HPV CSP01
Public Health England
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
GlaxoSmithKline
Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents
GlaxoSmithKline
Girasol
Johns Hopkins Bloomberg School of Public Health
Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection
AGUNCO Obstetrics and Gynecology Centre
TANGO
National Institute for Public Health and the Environment (RIVM)
Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China
ChineseAMS